Live: Supermicro Reports Q3 Earnings Tonight. Can Strong Results Spark a Rebound?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | May 3, 2017 at 11:10 AM EDT

Gilead Faces Serious Conundrum: Value Trap vs Real Value

Many value investors have flocked to Gilead Sciences as the world's top biotech stock now that it is valued at…

Chris Lange | May 2, 2017 at 8:50 AM EDT

Pfizer Sinks on Mixed Q1 Earnings

Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.

Jon C. Ogg | May 1, 2017 at 12:05 PM EDT

Valeant Still Has a Long Way to Go on Paying Down Its Debt

Following the closing of the sale of three skincare brands to L'Oréal and after the closing of the divestiture of…

Chris Lange | May 1, 2017 at 8:50 AM EDT

Intra-Cellular Therapies Sinks on FDA Update

Intra-Cellular Therapies saw its stock crumble early on Monday after the company provided an update on its plan to submit…

Chris Lange | Apr 26, 2017 at 11:30 AM EDT

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

24/7 Wall St. has put together a preview of some of the world’s largest biotech and pharma companies reporting their…

Chris Lange | Apr 26, 2017 at 9:40 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The April 13 short interest data have been compared with the previous report, and moves in the selected biotech stocks…

Chris Lange | Apr 26, 2017 at 8:25 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Pharma

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Apr 25, 2017 at 10:30 AM EDT

Analysts Try to Defend Express Scripts After Anthem Contract Loss

Express Scripts is among the biggest large cap losers on Wall Street on Tuesday. It's as if the market bounce…

Chris Lange | Apr 21, 2017 at 9:45 AM EDT

XBiotech Stock Crumbles Following Disappointing EMA Meeting

XBiotech saw its shares fall sharply after the company issued an update on its recent meeting with the European Medical…

Chris Lange | Apr 20, 2017 at 10:25 AM EDT

Why Immune Pharmaceuticals Shares Are Skyrocketing

Shares of Immune Pharmaceuticals saw an incredible gain in Thursday’s session following the announcement of an exclusive license agreement.

Chris Lange | Apr 19, 2017 at 11:30 AM EDT

Edge Therapeutics Rises Following Registered Direct Offering Announcement

Shares of Edge Therapeutics posted a solid gain in Wednesday’s trading session after the company announced that it would be…

Chris Lange | Apr 19, 2017 at 9:55 AM EDT

Audentes Therapeutics Gears Up for Secondary Offering

Audentes Therapeutics saw its shares drop early on Wednesday after the company announced the pricing of its secondary offering.

Chris Lange | Apr 19, 2017 at 8:55 AM EDT

Why One Analyst Is Growing Very Bullish on Life Sciences

Over the past five, 10 and 20 years, the life science and bioproduction segments have tended to outperform the S&P…

Chris Lange | Apr 18, 2017 at 10:35 AM EDT

Arena Pharmaceuticals Sinks After Announcing Secondary Offering

Arena Pharmaceuticals saw its shares drop sharply on Tuesday after the company announced a secondary offering of 60 million shares…

Paul Ausick | Apr 18, 2017 at 9:35 AM EDT

Why Johnson & Johnson Raised Guidance After Missing Sales Estimates

Health care giant Johnson & Johnson missed sales estimates but beat analysts' profit target. The $30 billion acquisition of Actelion…

1 … 168 169 170 171 172 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Gilead Faces Serious Conundrum: Value Trap vs Real Value

Pfizer Sinks on Mixed Q1 Earnings

Valeant Still Has a Long Way to Go on Paying Down Its Debt

Intra-Cellular Therapies Sinks on FDA Update

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Can’t Make Up Their Minds on Major Pharma

Analysts Try to Defend Express Scripts After Anthem Contract Loss

XBiotech Stock Crumbles Following Disappointing EMA Meeting

Why Immune Pharmaceuticals Shares Are Skyrocketing

Edge Therapeutics Rises Following Registered Direct Offering Announcement

Audentes Therapeutics Gears Up for Secondary Offering

Why One Analyst Is Growing Very Bullish on Life Sciences

Arena Pharmaceuticals Sinks After Announcing Secondary Offering

Why Johnson & Johnson Raised Guidance After Missing Sales Estimates

Live: Supermicro Reports Q3 Earnings Tonight. Can Strong Results Spark a Rebound?

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Health and Healthcare Articles

All Health and Healthcare Articles

Gilead Faces Serious Conundrum: Value Trap vs Real Value

Pfizer Sinks on Mixed Q1 Earnings

Valeant Still Has a Long Way to Go on Paying Down Its Debt

Intra-Cellular Therapies Sinks on FDA Update

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Short Sellers Grow More Selective on Major Biotechs

Short Sellers Can’t Make Up Their Minds on Major Pharma

Analysts Try to Defend Express Scripts After Anthem Contract Loss

XBiotech Stock Crumbles Following Disappointing EMA Meeting

Why Immune Pharmaceuticals Shares Are Skyrocketing

Edge Therapeutics Rises Following Registered Direct Offering Announcement

Audentes Therapeutics Gears Up for Secondary Offering

Why One Analyst Is Growing Very Bullish on Life Sciences

Arena Pharmaceuticals Sinks After Announcing Secondary Offering

Why Johnson & Johnson Raised Guidance After Missing Sales Estimates

Live: Supermicro Reports Q3 Earnings Tonight. Can Strong Results Spark a Rebound?

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: Lumentum Q3 Earnings Tonight. Can the 15x Surge Continue?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Featured Reads

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income